New, multi-million dollar grants come from the British, German, and Canadian governments. By Katherine Gianni Since its founding in 2016, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has served as a global non-profit partnership dedicated to accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world…